Catheter Ablation Trial Criteria For AF Therapy Clarified In FDA Guidance
This article was originally published in The Gray Sheet
Executive Summary
Commercialization of CryoCath's catheter ablation system to treat atrial fibrillation could be delayed up to six months due to FDA follow-up data recommendations